USP Comment Letter: Submitted to FDA on ICH-Q12 - Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management (2018)

Submitted December 14, 2018 - USP Comment Letter to FDA on draft guidance: Q12 Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management. Docket No. FDA-2018-D-1609.